• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Early intervention in schizophrenia: current and future perspectives.

作者信息

Keshavan Matcheri S, Amirsadri Ali

机构信息

Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI 48201, USA.

出版信息

Curr Psychiatry Rep. 2007 Aug;9(4):325-8. doi: 10.1007/s11920-007-0040-8.

DOI:10.1007/s11920-007-0040-8
PMID:17880865
Abstract

The last decade has witnessed an expanding interest in the concept of early intervention (EI) in psychotic disorders, notably schizophrenia. This is supported by the well-established association between prolonged untreated illness duration and poor outcome, as well as some evidence of progressive neurobiological changes in the early course of schizophrenia, both in the prepsychotic and psychotic phases as evidenced by brain imaging studies in schizophrenia. Increasingly, mental health service systems around the world have been incorporating specialized EI programs. Controlled effectiveness studies in recent years have yielded encouraging data. Several questions in regard to the timing, choice of interventions, and the populations most likely to benefit from EIs still remain. More evidence-based data are needed to place the EI models in schizophrenia on firm footing in order to effectively implement them in the resource-strapped community mental health service settings.

摘要

相似文献

1
Early intervention in schizophrenia: current and future perspectives.
Curr Psychiatry Rep. 2007 Aug;9(4):325-8. doi: 10.1007/s11920-007-0040-8.
2
Early intervention in psychotic disorders: Challenges and relevance in the Indian context.精神病性障碍的早期干预:印度背景下的挑战和相关性。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S153-8. doi: 10.4103/0019-5545.69228.
3
The use of pharmacotherapy in the prodrome of schizophrenia.
CNS Spectr. 2004 Aug;9(8):579-86. doi: 10.1017/s1092852900002741.
4
Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.精神分裂症的早期干预:前驱期抗精神病药物治疗的风险效益比
Am J Psychiatry. 2011 Aug;168(8):761-3. doi: 10.1176/appi.ajp.2011.11050765.
5
Toward a better identification and treatment of schizophrenia prodrome.迈向对精神分裂症前驱期的更好识别与治疗。
Bull Menninger Clin. 2008 Summer;72(3):210-27. doi: 10.1521/bumc.2008.72.3.210.
6
Psychosis treatment prior to psychosis onset: ethical issues.精神病发作前的精神病治疗:伦理问题。
Schizophr Res. 2001 Aug 1;51(1):47-54. doi: 10.1016/s0920-9964(01)00238-9.
7
Prodromal schizophrenia: the dilemma of prediction and early intervention.前驱期精神分裂症:预测与早期干预的困境
CNS Spectr. 2004 Aug;9(8):578. doi: 10.1017/s109285290000273x.
8
[Dilemma of early drug intervention in prepsychotic illnesses of adolescence].[青少年精神病前期疾病早期药物干预的困境]
Prax Kinderpsychol Kinderpsychiatr. 2003 Dec;52(10):751-65.
9
Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.
J Clin Psychiatry. 2009;70 Suppl 1:4-46.
10
Beating psychosis to the punch: the treatment options debate.
CNS Spectr. 2004 Aug;9(8):572. doi: 10.1017/s1092852900002716.

引用本文的文献

1
Macro- and Microstructural Alterations in the Midbrain in Early Psychosis Associates with Clinical Symptom Scores.早期精神病患者中脑的宏观和微观结构改变与临床症状评分相关。
eNeuro. 2025 Mar 19;12(3). doi: 10.1523/ENEURO.0361-24.2025. Print 2025 Mar.
2
Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability.用棕榈酸帕利哌酮治疗近期病情加重的精神分裂症患者:疗效和耐受性的初步研究。
Neuropsychiatr Dis Treat. 2020 Sep 10;16:2063-2072. doi: 10.2147/NDT.S233537. eCollection 2020.
3
Disclosure of psychiatric manifestations of 22q11.2 deletion syndrome in medical genetics: A 12-year retrospective chart review.

本文引用的文献

1
Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?超高风险(前驱期)服务中过渡率下降:风险稀释还是降低?
Schizophr Bull. 2007 May;33(3):673-81. doi: 10.1093/schbul/sbm015. Epub 2007 Apr 2.
2
Early intervention for psychosis.精神病的早期干预
Cochrane Database Syst Rev. 2006 Oct 18(4):CD004718. doi: 10.1002/14651858.CD004718.pub2.
3
Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia.
医学遗传学中22q11.2缺失综合征精神症状的披露:一项为期12年的回顾性病历审查。
Am J Med Genet A. 2015 Oct;167A(10):2350-6. doi: 10.1002/ajmg.a.37190. Epub 2015 May 31.
4
Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.首发精神分裂症受试者中每月 1 次注射用棕榈酸帕利哌酮的长期耐受性。
Neuropsychiatr Dis Treat. 2012;8:375-85. doi: 10.2147/NDT.S32581. Epub 2012 Aug 27.
5
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? results of a retrospective study.未治疗精神病持续时间是否预测精神分裂症障碍的极长期结局?一项回顾性研究的结果。
Ann Gen Psychiatry. 2012 Aug 2;11(1):21. doi: 10.1186/1744-859X-11-21.
6
Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment.神经精神病学分期:一种用于理解、预防和治疗的启发式模型。
Neurotox Res. 2010 Nov;18(3-4):244-55. doi: 10.1007/s12640-010-9179-x. Epub 2010 Apr 3.
7
Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.精神病和情感障碍病理生理学的临床分期:改善预后和治疗。
Neurotox Res. 2010 Nov;18(3-4):211-28. doi: 10.1007/s12640-010-9161-7. Epub 2010 Mar 17.
8
Formal thought disorder and the autism spectrum: relationship with symptoms, executive control, and anxiety.形式思维障碍与自闭症谱系:与症状、执行控制及焦虑的关系
J Autism Dev Disord. 2008 Sep;38(8):1474-84. doi: 10.1007/s10803-007-0526-6. Epub 2008 Feb 23.
首次发作精神病风险受试者与首次发作及多次发作精神分裂症患者的神经认知功能比较
J Clin Exp Neuropsychol. 2006 Nov;28(8):1388-407. doi: 10.1080/13803390500434425.
4
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).第二代与第一代抗精神病药物对精神分裂症患者生活质量影响的随机对照试验:精神分裂症最新抗精神病药物的成本效用研究(CUtLASS 1)
Arch Gen Psychiatry. 2006 Oct;63(10):1079-87. doi: 10.1001/archpsyc.63.10.1079.
5
Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions.精神疾病的临床分期:一个用于选择更早、更安全且更有效干预措施的启发式框架。
Aust N Z J Psychiatry. 2006 Aug;40(8):616-22. doi: 10.1080/j.1440-1614.2006.01860.x.
6
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.奥氮平与安慰剂治疗精神病前驱症状患者的随机双盲试验。
Am J Psychiatry. 2006 May;163(5):790-9. doi: 10.1176/ajp.2006.163.5.790.
7
Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment.OPUS试验中首次就诊患者从分裂型障碍转变为精神障碍的转化率。一项综合治疗与标准治疗的随机临床试验。
Schizophr Res. 2006 Mar;83(1):29-40. doi: 10.1016/j.schres.2006.01.002. Epub 2006 Feb 28.
8
Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.首发精神分裂症未治疗精神病持续时间与预后的关系:一项批判性综述与荟萃分析。
Am J Psychiatry. 2005 Oct;162(10):1785-804. doi: 10.1176/appi.ajp.162.10.1785.
9
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.抗精神病药物对慢性精神分裂症患者的疗效。
N Engl J Med. 2005 Sep 22;353(12):1209-23. doi: 10.1056/NEJMoa051688. Epub 2005 Sep 19.
10
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review.首发患者队列中未治疗精神病持续时间与结局的关联:一项系统评价
Arch Gen Psychiatry. 2005 Sep;62(9):975-83. doi: 10.1001/archpsyc.62.9.975.